Chengqiang Yin

822 citations
14 papers · 701 indexed · h-index 10
Topics
Cancer-related molecular mechanisms research (8 papers)MicroRNA in disease regulation (7 papers)Circular RNAs in diseases (5 papers)

In The Last Decade

Chengqiang Yin

13 papers receiving 695 citations

Peers

Chengqiang Yin
Comparison fields: 5 of 65
  • Cancer Research 569
  • Molecular Biology 529
  • Surgery 95
  • Epidemiology 77
  • Pulmonary and Respiratory Medicine 49
Replace Xiaoran Long with:
Xiaoran Long China
Shail Maheshwari United States
Yeben Qian China
Canhui Jin China
Simona Cagiano Italy
Erdun Bao China
Shounan Lu China
Chengqiang Yin relative to Xiaoran Long China Xiaoran Long's profile →
Citations per field
00.5×3.6×
Xiaoran Long · 1×
Citations per year

Countries citing papers authored by Chengqiang Yin

Since Specialization
Citations

This map shows the geographic impact of Chengqiang Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengqiang Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengqiang Yin more than expected).

Fields of papers citing papers by Chengqiang Yin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengqiang Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengqiang Yin. The network helps show where Chengqiang Yin may publish in the future.

Co-authorship network of co-authors of Chengqiang Yin

This figure shows the co-authorship network connecting the top 25 collaborators of Chengqiang Yin. A scholar is included among the top collaborators of Chengqiang Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengqiang Yin. Chengqiang Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 0
2 2
3 21
4 5
5 9
6
FZD6, targeted by miR-21, represses gastric cancer cell proliferation and migration via activating non-canonical wnt pathway.
39
7 189
8 279
9 6
10 26
11
Clinical role of circulating miR-223 as a novel biomarker in early diagnosis of cancer patients.
24
12 18
13 62
14 21

About Chengqiang Yin

Chengqiang Yin is a scholar working on Cancer Research, Transplantation and Small Animals, having authored 14 papers that have together received 701 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (7 papers) and Circular RNAs in diseases (5 papers). The work is most often cited by research in Cancer Research (569 citations), Molecular Biology (529 citations) and Transplantation (18 citations). Chengqiang Yin has collaborated with scholars based in China, Switzerland and South Sudan. Frequent co-authors include Guoxin Zhang, Xiaoying Zhou, Yini Dang, Feng Ye, Feng Ye, Yue Ge, Guifang Xu, Yan Jin, Tingyu Liu and Jin Yan. Their work appears in journals such as Scientific Reports, Antimicrobial Agents and Chemotherapy and Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026